Inventor
DE ANGELIS FRANCESCO
IT20 patents
⚠️ This page may combine multiple inventors who share the name “DE ANGELIS FRANCESCO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SIGMA TAU IND FARMACEUTI
15 patentsUS6369073B1Apr 9, 2002
Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase
SIGMA TAU IND FARMACEUTI95 citations96
US6444701B1Sep 3, 2002
Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase
SIGMA TAU IND FARMACEUTI19 citations91
US6420599B2Jul 16, 2002
Chemical process for the stereoselective synthesis of R-(-)-carnitine
SIGMA TAU IND FARMACEUTI7 citations73
US5491260AFeb 13, 1996
Process for manufacturing L-(-)-carnitine from derivatives having a configuration opposite to that of L-(-)-carnitine
SIGMA TAU IND FARMACEUTI9 citations72
US6822115B2Nov 23, 2004
Synthesis of (R) and (S)-aminocarnitine, (R) and (S)-4-phosphonium-3-amino-butanoate, (R) and (S) 3,4-diaminobutanoic acid, and their derivatives starting from D- and L-aspartic acid
SIGMA TAU IND FARMACEUTI8 citations71
US6528684B1Mar 4, 2003
Synthesis of (R) and (S) -aminocarnitine and their derivatives starting from D- and L-aspartic acid
SIGMA TAU IND FARMACEUTI10 citations71
US5412113AMay 2, 1995
Process for manufacturing L-(-)-carnitine from a waste product having opposite configuration
SIGMA TAU IND FARMACEUTI10 citations71
US6127552AOct 3, 2000
Process for producing (R)-3-hydroxy-4-butyrolactone useful for preparing (R)-carnitine
SIGMA TAU IND FARMACEUTI2 citations62
US5714619AFeb 3, 1998
Process for the preparation of (S)-β-hydroxy-γ-butyrolactone
SIGMA TAU IND FARMACEUTI2 citations62
USRE41226EApr 13, 2010
Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase
SIGMA TAU IND FARMACEUTI1 citations61
USRE40861EJul 21, 2009
Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase
SIGMA TAU IND FARMACEUTI1 citations61
US5532409AJul 2, 1996
Process for producing R-aminocarnitine and S-aminocarnitine
SIGMA TAU IND FARMACEUTI5 citations61
US5599978AFeb 4, 1997
Process for manufacturing L-(-)-carnitine from a waste product having opposite configuration
SIGMA TAU IND FARMACEUTI4 citations60
US5532410AJul 2, 1996
Process for manufacturing L(-)-carnitine from a waste product having opposite configuration
SIGMA TAU IND FARMACEUTI4 citations59
US6316667B2Nov 13, 2001
Process for the preparation of R-(-)-carnitine
SIGMA TAU IND FARMACEUTI0 citations52